{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T06:11:51Z","timestamp":1777961511670,"version":"3.51.4"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Vancomycin-resistant\n                      <jats:italic>Enterococcus faecium<\/jats:italic>\n                      (VR-Efm) has shown a rising global trend. This study aimed to analyze the resistance patterns and risk factors of\n                      <jats:italic>E. faecium<\/jats:italic>\n                      bloodstream infections (BSIs) in hospitalized patients at a Chinese tertiary hospital in Guangzhou, to provide evidence for infection control.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This is a retrospective study investigating the antimicrobial susceptibility profiles and clinical characteristics of 48\n                      <jats:italic>E. faecium<\/jats:italic>\n                      isolates recovered from 48 hospitalized patients (one isolate per patient) between 1st January 2022 and 31st December 2024, with all cases meeting the predefined clinical and microbiological diagnostic criteria for bloodstream infections. For patients with multiple positive blood cultures, only the first isolate was included to avoid duplication bias.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 48 patients with BSIs were included in the final analysis. Among these 48\n                      <jats:italic>E. faecium<\/jats:italic>\n                      bloodstream isolates, the vancomycin resistance rate was 31.25% (15\/48). The proportion of intensive care unit (ICU) patients was significantly higher in the VR-Efm group than in the vancomycin-susceptible\n                      <jats:italic>E. faecium<\/jats:italic>\n                      (VS-Efm) group (73.33% vs. 39.39%,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.029). No significant differences were observed between the two groups regarding underlying comorbidities (hypertension, coronary artery disease, and diabetes mellitus), history of drug\/food allergies, surgery, hepatitis, tuberculosis, or blood transfusion (\n                      <jats:italic>p<\/jats:italic>\n                      &amp;gt;\u202f0.05). Moreover, the mortality rate of patients with VR-Efm BSIs was markedly higher than that of those with VS-Efm infections (46.67% vs. 18.18%,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.040). ICU admission (OR\u202f=\u202f3.31, 95% CI 1.71\u20138.48,\n                      <jats:italic>p<\/jats:italic>\n                      =\u202f0.029) and prior exposure to glycopeptides (OR\u202f=\u202f7.87, 95% CI 1.21\u201321.16,\n                      <jats:italic>p<\/jats:italic>\n                      =\u202f0.031) remained independently associated with VR-Efm infection.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      In this single-center retrospective study, the vancomycin resistance rate among\n                      <jats:italic>E. faecium<\/jats:italic>\n                      bloodstream isolates was 31.25%. ICU admission and prior glycopeptide exposure were identified as independent risk factors for VR-Efm bloodstream infections. Patients with VR-Efm BSIs had significantly higher mortality than those with VS-Efm infections. Although all isolates remained susceptible to linezolid, the high resistance rate and its association with worse clinical outcomes underscore the urgent need for strengthened antimicrobial stewardship, enhanced surveillance, and targeted infection control measures, particularly in ICUs and among patients with prior glycopeptide exposure.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1771155","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T05:32:30Z","timestamp":1777959150000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Antimicrobial resistance patterns and risk factors of Enterococcus faecium bloodstream infections in hospitalized patients in a Chinese tertiary care hospital"],"prefix":"10.3389","volume":"14","author":[{"given":"Chuyu","family":"Lao","sequence":"first","affiliation":[{"name":"Department of Pharmacy, The First Affiliated Hospital of Sun Yat-sen University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zihuan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Infection Prevention and Control, The Affiliated Guangdong Second Provincial General Hospital of Jinan University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanwen","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Infection Prevention and Control, The Affiliated Guangdong Second Provincial General Hospital of Jinan University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuiqiong","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Infection Prevention and Control, The Affiliated Guangdong Second Provincial General Hospital of Jinan University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maorui","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The Affiliated Guangdong Second Provincial General Hospital of Jinan University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"100732","DOI":"10.1016\/j.drup.2020.100732","article-title":"Thirty years of vre in Germany \u2013 \u201cexpect the unexpected\u201d: the view from the national reference Centre for staphylococci and enterococci","volume":"53","author":"Werner","year":"2020","journal-title":"Drug Resist Updat"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1055\/a-0655-6454","article-title":"Enterococci with special resistance patterns \u2013 epidemiology, hygiene and therapy","volume":"144","author":"Mischnik","year":"2019","journal-title":"Dtsch Med Wochenschr"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13756-018-0353-x","article-title":"Continuous increase of vancomycin resistance in enterococci causing nosocomial infections in Germany \u2013 10 years of surveillance","volume":"7","author":"Remschmidt","year":"2018","journal-title":"Antimicrob Resist Infect Control"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2361030","DOI":"10.1080\/22221751.2024.2361030","article-title":"Emergence and ongoing outbreak of st80 vancomycin-resistant enterococcus faecium in Guangdong province, China from 2021 to 2023: a multicenter, time-series and genomic epidemiological study","volume":"13","author":"Shen","year":"2024","journal-title":"Emerg Microbes Infect"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1093\/jac\/dkaf242","article-title":"Impact of vancomycin resistance on attributable mortality among enterococcus faecium bloodstream infections: propensity score analysis of a large, multicentre retrospective study","volume":"80","author":"Del","year":"2025","journal-title":"J Antimicrob Chemother"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jgar.2019.10.008","article-title":"Efficacy and safety of daptomycin versus linezolid treatment in patients with vancomycin-resistant enterococcal bacteraemia: an updated systematic review and meta-analysis","volume":"21","author":"Shi","year":"2020","journal-title":"J Glob Antimicrob Resist"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"e5922","DOI":"10.1128\/cmr.00059-22","article-title":"Therapeutics for vancomycin-resistant enterococcal bloodstream infections","volume":"36","author":"Cairns","year":"2023","journal-title":"Clin Microbiol Rev"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"dkag069","DOI":"10.1093\/jac\/dkag069","article-title":"Vancomycin resistance predicts increased mortality in patients with enterococcus faecium bloodstream infections: a six-year experience at a large tertiary care Italian hospital","volume":"81","author":"Graziani","year":"2026","journal-title":"J Antimicrob Chemother"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1727877","DOI":"10.3389\/fcimb.2025.1727877","article-title":"Epidemiological characteristics and antimicrobial resistance of pathogens isolated from blood cultures in southern Jiangxi, China, 2020-2024","volume":"15","author":"Liu","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jgar.2024.11.002","article-title":"Surveillance and characteristics of vancomycin-resistant enterococcus isolates in a chinese tertiary hospital in Shenzhen, 2018 to 2024","volume":"40","author":"Shen","year":"2025","journal-title":"J Glob Antimicrob Resist."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2200285","DOI":"10.2807\/1560-7917.ES.2022.27.48.2200285","article-title":"Nosocomial outbreak of vancomycin-resistant enterococcus faecium (vre) st796, Switzerland, 2017 to 2020","volume":"27","author":"Piezzi","year":"2022","journal-title":"Euro Surveill"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/2047-2994-1-21","article-title":"Vancomycin-resistant vanb-type enterococcus faecium isolates expressing varying levels of vancomycin resistance and being highly prevalent among neonatal patients in a single icu","volume":"1","author":"Werner","year":"2012","journal-title":"Antimicrob Resist Infect Control"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1017\/ice.2015.228","article-title":"Vre and vse bacteremia outcomes in the era of effective vre therapy: a systematic review and meta-analysis","volume":"37","author":"Prematunge","year":"2016","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jhin.2023.09.008","article-title":"Epidemiology and outcomes of vancomycin-resistant enterococcus infections: a systematic review and meta-analysis","volume":"141","author":"Eichel","year":"2023","journal-title":"J Hosp Infect"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.ajic.2016.10.002","article-title":"A polyclonal outbreak of bloodstream infections by Enterococcus faecium in patients with hematologic malignancies","volume":"45","author":"Alatorre-Fernandez","year":"2017","journal-title":"Am J Infect Control"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13756-020-0683-3","article-title":"Does vancomycin resistance increase mortality in enterococcus faecium bacteraemia after orthotopic liver transplantation? A retrospective study","volume":"9","author":"Dubler","year":"2020","journal-title":"Antimicrob Resist Infect Control"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13756-023-01332-x","article-title":"Vancomycin resistant enterococcus risk factors for hospital colonization in hematological patients: a matched case-control study","volume":"12","author":"Meschiari","year":"2023","journal-title":"Antimicrob Resist Infect Control"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"117620","DOI":"10.1016\/j.ejmech.2025.117620","article-title":"Redesigning oxazolidinones as carbonic anhydrase inhibitors against vancomycin-resistant enterococci","volume":"291","author":"Ammara","year":"2025","journal-title":"Eur J Med Chem"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14030261","article-title":"Isolation of vanA-Mediated Vancomycin-Resistant Enterococcus faecalis (ST1912\/CC116) and Enterococcus faecium (ST80\/CC17), optrA-Positive Linezolid-Resistant E. faecalis (ST32, ST1902) from Human Clinical Specimens in Bangladesh","volume":"14","author":"Roy","year":"2025","journal-title":"Antibiotics (Basel)"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"720647","DOI":"10.3389\/fmed.2021.720647","article-title":"The global prevalence of daptomycin, tigecycline, and linezolid-resistant enterococcus faecalis and enterococcus faecium strains from human clinical samples: a systematic review and meta-analysis","volume":"8","author":"Dadashi","year":"2021","journal-title":"Front Med"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1771155\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T05:32:31Z","timestamp":1777959151000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1771155\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":20,"alternative-id":["10.3389\/fpubh.2026.1771155"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1771155","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,5]]},"article-number":"1771155"}}